By: Allen Wilbanks
Date: September 27, 2023
Myeloproliferative neoplasms (MPNs) are a group of blood disorders characterized by the overproduction of blood cells in the bone marrow. Andrew Kuykendall, MD, a well-known hematopathologist and engaging speaker, recently addressed the topic of “WHO versus ICC and the Implications within MPNs” in a presentation. Despite not being directly involved in either classification system, Dr. Kuykendall offered a unique third-party perspective on the matter, comparing and contrasting the two systems and their implications for MPNs.
Dr. Andrew Kuykendall, MD, is a renowned figure in the field of hematopathology and an engaging speaker known for his insightful perspectives, even on social media platforms like Twitter. In a recent presentation, he discussed the intriguing topic of “WHO versus ICC and the Implications within MPNs.” Despite not being directly involved in either classification system, Dr. Kuykendall offered a unique third-party perspective on the matter, comparing and contrasting the two systems and their implications for myeloproliferative neoplasms (MPNs).
With a touch of humor, Dr. Kuykendall likened his role in this discourse to that of a marriage counselor, aiming to mediate between the WHO and ICC classification systems. He began by delving into the reasons behind the existence of two separate systems and explored the rationale behind the ICC’s decision to develop its classification system alongside the WHO’s fifth edition.
He highlighted the differences in the formation of guidelines between the ICC and WHO, illustrating the intricate processes involved in each. The ICC’s approach emphasized the involvement of clinical and pathology co-chairs, subgroups, and meetings, while the WHO relied on an editorial board, expert members, and authors identified through a bibliography process.